Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine safety and efficacy of silodosin, which is a
treatment for benign prostatic hyperplasia with high selectivity to α1A-receptor, on patients
with benign prostatic hyperplasia accompanied by nocturia.